Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 100

Sort by

Sort Order Select

Journal Articles

A New Clinically-Based Subclassification Proposal in CMML with Significant Prognostic Implications to Overcome the MDS/MPN Categorizing Dilemma

Blood (2016) 128 (22): 4320.

https://doi.org/10.1182/blood.V128.22.4320.4320

Published: 2016

Journal Articles

Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series

Jennifer Yui, MD, Mythri Mudireddy, MBBS, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Aref Al-Kali, MD, Michelle Elliott, MD, William J. Hogan, MBChB, C. Christopher Hook, MD, Alexandra P Wolanskyj, MD, Mark R. Litzow, MD, Matthew T Howard, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Kebede H. Begna, MD

Blood (2016) 128 (22): 2798.

https://doi.org/10.1182/blood.V128.22.2798.2798

Published: 2016

Journal Articles

Monocytosis in Polycythemia Vera: Clinical and Molecular Correlates

Daniela Barraco, MD, Sonia Cerquozzi, MD, Naseema Gangat, MBBS, Mrinal M Patnaik, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2016) 128 (22): 4259.

https://doi.org/10.1182/blood.V128.22.4259.4259

Published: 2016

Journal Articles

Number and Type of TET2 Mutations in Chronic Myelomonocytic Leukemia: Clinical and Prognostic Correlates

Mrinal M Patnaik, MBBS, Mohammad Faizan Zahid, Terra L. Lasho, PhD, Ezequiel Tolosa, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Eric Solary, MD Prof, Keith D Robertson, PhD, Naseema Gangat, MBBS, Martin E. Fernandez-Zapico, MD, Ayalew Tefferi, MD

Blood (2016) 128 (22): 4343.

https://doi.org/10.1182/blood.V128.22.4343.4343

Published: 2016

Journal Articles

Clinical Outcomes Related to the Use of Monoclonal Antibody Therapy for Steroid Refractory Acute Graft-Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Fevzi Yalniz, MD, Mehrdad Hefazi, MD, Kristen B. McCullough, PharmD, Mark Litzow, MD, William J Hogan, MBChB, Robert C Wolf, PharmD, Hassan B Alkhateeb, MD, Ankit Kansagra, Moussab Damlaj, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 4593.

https://doi.org/10.1182/blood.V128.22.4593.4593

Published: 2016

Journal Articles

Outcome of Elderly Patients after Failure to Hypomethylating Agents Given As Frontline Therapy for Acute Myeloid Leukemia (AML): Single Institution Experience

Rama Nanah, MD, Kristen B. McCullough, PharmD, William J Hogan, MBChB, Kebede H. Begna, MD, Naseema Gangat, MBBS, Mrinal M Patnaik, MBBS, Michelle Ann Elliott, MB, BCh, Mark Litzow, MD, Aref Al-Kali, MD

Blood (2016) 128 (22): 1617.

https://doi.org/10.1182/blood.V128.22.1617.1617

Published: 2016

Journal Articles

A Phase 2 Study of Pracinostat and Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Not Eligible for Induction Chemotherapy: Response and Long-Term Survival Benefit

Guillermo Garcia Manero, Ehab Atallah, MD, Samer K Khaled, MD, Martha Arellano, MD, Mrinal M Patnaik, MBBS, Olatoyosi Odenike, MD, Hamid Sayar, MD, Mohan Tummala, Prapti A. Patel, MD, Richard G. Ghalie, MD, Bruno C. Medeiros, MD

Blood (2016) 128 (22): 100.

https://doi.org/10.1182/blood.V128.22.100.100

Published: 2016

Journal Articles

Gene Expression Profiling Identifies Distinct Signatures for Dysplastic and Proliferative Chronic Myelomonocytic Leukemia

Mrinal M Patnaik, MBBS, Daniela Barraco, MD, Terra L. Lasho, PhD, Ezequiel Tolosa, PhD, Luciana L. Almada, PhD, Jaime I Davila, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Éric Solary, MD PhD, Nathalie M. Droin, PhD, Naseema Gangat, MBBS, Aref Al-Kali, MD, Martin E. Fernandez-Zapico, MD, Ayalew Tefferi, MD

Blood (2016) 128 (22): 110.

https://doi.org/10.1182/blood.V128.22.110.110

Published: 2016

Journal Articles

Coagulation Abnormalities and Hemostatic Surgical Outcomes in 142 Patients with Noonan Syndrome

Juliana Perez Botero, MD, Thanh Ho, MD, Vilmarie Rodriguez, MD, Shaquila P Khan, MD, Rajiv K. Pruthi, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 1417.

https://doi.org/10.1182/blood.V128.22.1417.1417

Published: 2016

Journal Articles

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

Mehrdad Hefazi, MD, Mrinal M Patnaik, MBBS, William J Hogan, MBChB, Mark R Litzow, MD, Darrell S Pardi, MD, Sahil Khanna, MBBS

Blood (2016) 128 (22): 3599.

https://doi.org/10.1182/blood.V128.22.3599.3599

Published: 2016

Journal Articles

Outcome of Myelodysplastic Syndromes over Time in the US: A National Cancer Data Base Study from 2004-2013

Aref Al-Kali, MD, Darci Zblewski, CNP, Adam C Bartley, MS, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Kebede H. Begna, MD, Ayalew Tefferi, MD, Michelle Elliott, MD, William J Hogan, MBChB, Mark R. Litzow, MD, Ronald S. Go, MD

Blood (2016) 128 (22): 3604.

https://doi.org/10.1182/blood.V128.22.3604.3604

Published: 2016

Journal Articles

Next-Generation Sequencing in Myelodysplastic Syndromes: Prognostic Interaction Between Adverse Mutations and IPSS-R

Naseema Gangat, MBBS, Terra L. Lasho, PhD, Lyla Saeed, MBBS, Mythri Mudireddy, MBBS, Mrinal M Patnaik, MBBS, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2016) 128 (22): 1986.

https://doi.org/10.1182/blood.V128.22.1986.1986

Published: 2016

Journal Articles

"Proliferative" Versus "Dysplastic" Chronic Myelomonocytic Leukemia: Molecular and Prognostic Correlates

Mrinal M Patnaik, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Matthew T Howard, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 1987.

https://doi.org/10.1182/blood.V128.22.1987.1987

Published: 2016

Journal Articles

DNTM3A Mutations and Prognosis in Chronic Myelomonocytic Leukemia

Mrinal M Patnaik, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Matthew T Howard, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 1988.

https://doi.org/10.1182/blood.V128.22.1988.1988

Published: 2016

Journal Articles

Spectrum of Concomitant and Subsequently Diagnosed Second Malignancies in Patients with Chronic Myelomonocytic Leukemia

Daniela Barraco, MD, Terra L. Lasho, PhD, Christy Finke, BS, Aref Al-Kali, MD, Michelle Elliott, MD, Mark R. Litzow, MD, Naseema Gangat, MBBS, Curtis A. Hanson, MD, Ayalew Tefferi, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 1989.

https://doi.org/10.1182/blood.V128.22.1989.1989

Published: 2016

Journal Articles

Prognostic Relevance of Monocytopenia and Lymphocyte-to-Monocyte Ratio in Primary Myelodysplastic Syndromes

Lyla Saeed, MBBS, Mrinal M Patnaik, MBBS, Kebede H. Begna, MD, Aref Al-Kali, MD, Mark R Litzow, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 1996.

https://doi.org/10.1182/blood.V128.22.1996.1996

Published: 2016

Journal Articles

Radius: A Phase 2, Randomized Trial of Standard of Care (SOC) with or without Midostaurin to Prevent Relapse Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients (pts) with FLT3 -Itd-Mutated Acute Myeloid Leukemia (AML)

Richard T. Maziarz, MD, Mrinal M Patnaik, MBBS, Bart L. Scott, MD, Sanjay R. Mohan, MD, Abhinav Deol, MD, Scott D. Rowley, MD FACP, Dennis Dong Hwan Kim, MD PhD, Kelly Haines, BS, Gaetano Bonifacio, MD, Patrice Rine, Hugo F. Fernandez, MD

Blood (2016) 128 (22): 2248.

https://doi.org/10.1182/blood.V128.22.2248.2248

Published: 2016

Journal Articles

Subnormal Lymphocyte Count Predicts Inferior Survival in Myelodysplastic Syndromes: A Single Center Experience in 889 Patients

Lyla Saeed, MBBS, Mrinal M Patnaik, MBBS, Kebede H. Begna, MD, Aref Al-Kali, MD, Curtis A. Hanson, MD, Mark R Litzow, MD, Rhett P. Ketterling, MD, Luis Porrata, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 5534.

https://doi.org/10.1182/blood.V128.22.5534.5534

Published: 2016

Journal Articles

Outcome of Patients Younger Than 50 Years Old Diagnosed with Myelodysplastic Syndromes (MDS): Single Institution Experience

Aref Al-Kali, MD, Rong He, MD, Mrinal M Patnaik, MBBS, David S Viswanatha, MD, Patricia T. Greipp, DO, Darci Zblewski, CNP, Michelle Elliott, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD, Mark R. Litzow, MD, Phuong L. Nguyen, MD

Blood (2016) 128 (22): 5541.

https://doi.org/10.1182/blood.V128.22.5541.5541

Published: 2016

Journal Articles

The 2016 Revised World Health Organization Classification of 'Myelodysplastic Syndrome with Isolated Del(5q)'; Prognostic Implications of Single Versus Double Cytogenetic Abnormalities

Mark Gurney, M.B B.Ch., Mrinal M Patnaik, MBBS, Curtis A. Hanson, MD, Mark R. Litzow, MD, Aref Al-Kali, MD, Rhett P. Ketterling, MD, Ayalew Tefferi, MD, Naseema Gangat, MBBS

Blood (2016) 128 (22): 5542.

https://doi.org/10.1182/blood.V128.22.5542.5542

Published: 2016

NARROW

A New Clinically-Based Subclassification Proposal in CMML with Significant Prognostic Implications to Overcome the MDS/MPN Categorizing Dilemma

Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series

Monocytosis in Polycythemia Vera: Clinical and Molecular Correlates

Number and Type of TET2 Mutations in Chronic Myelomonocytic Leukemia: Clinical and Prognostic Correlates

Clinical Outcomes Related to the Use of Monoclonal Antibody Therapy for Steroid Refractory Acute Graft-Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Outcome of Elderly Patients after Failure to Hypomethylating Agents Given As Frontline Therapy for Acute Myeloid Leukemia (AML): Single Institution Experience

A Phase 2 Study of Pracinostat and Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Not Eligible for Induction Chemotherapy: Response and Long-Term Survival Benefit

Gene Expression Profiling Identifies Distinct Signatures for Dysplastic and Proliferative Chronic Myelomonocytic Leukemia

Coagulation Abnormalities and Hemostatic Surgical Outcomes in 142 Patients with Noonan Syndrome

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

Outcome of Myelodysplastic Syndromes over Time in the US: A National Cancer Data Base Study from 2004-2013

Next-Generation Sequencing in Myelodysplastic Syndromes: Prognostic Interaction Between Adverse Mutations and IPSS-R

"Proliferative" Versus "Dysplastic" Chronic Myelomonocytic Leukemia: Molecular and Prognostic Correlates

DNTM3A Mutations and Prognosis in Chronic Myelomonocytic Leukemia

Spectrum of Concomitant and Subsequently Diagnosed Second Malignancies in Patients with Chronic Myelomonocytic Leukemia

Prognostic Relevance of Monocytopenia and Lymphocyte-to-Monocyte Ratio in Primary Myelodysplastic Syndromes

Radius: A Phase 2, Randomized Trial of Standard of Care (SOC) with or without Midostaurin to Prevent Relapse Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients (pts) with FLT3 -Itd-Mutated Acute Myeloid Leukemia (AML)

Subnormal Lymphocyte Count Predicts Inferior Survival in Myelodysplastic Syndromes: A Single Center Experience in 889 Patients

Outcome of Patients Younger Than 50 Years Old Diagnosed with Myelodysplastic Syndromes (MDS): Single Institution Experience

The 2016 Revised World Health Organization Classification of 'Myelodysplastic Syndrome with Isolated Del(5q)'; Prognostic Implications of Single Versus Double Cytogenetic Abnormalities

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only